Privia Health Group, Inc.
PRVANASDAQHealthcareHealth Information Services
As of Oct 15, 2026 close
- Market cap
- $2.98B
- P/E (TTM)
- 106.03
- Forward P/E
- 55.36
- Dividend yield
- -
- 52-week range
- $18.92$28.82
- Volume (live)
- -
- Avg. volume (3M)
- 1.37M
Privia Health Group (PRVA) Stock Price & Financial Analysis
Privia Health Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $21.89 - $22.73 |
|---|---|
| 52-Week High | $28.82 |
| 52-Week Low | $18.92 |
| Open | $21.97 |
| Volume (last close) | 2.00M |
| Average Volume (3M) | 1.37M |
| Revenue (TTM) | 2.36B |
|---|---|
| Net Income (TTM) | 28.12M |
| Free Cash Flow (TTM) | -48.24M |
| EPS (TTM) | $0.22 |
| Profit Margin | 1.19% |
| Operating Margin | 1.90% |
| Return on Equity (ROE) | 3.36% |
| Debt to Equity | 10.43 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 2.98B |
|---|---|
| Shares Outstanding | 131.83M |
| P/E Ratio (TTM) | 106.03 |
| Forward P/E | 55.36 |
| Price to Sales (P/S) | 1.26 |
| Price to Book (P/B) | 3.56 |
| EV/EBITDA | 171.66 |
| 50-Day MA | $20.80 |
|---|---|
| 200-Day MA | $22.75 |
| 1-Year Change | −11.40% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Privia Health Group at a Glance
As of the Oct 15, 2026 close, Privia Health Group (PRVA) has a market capitalization of $2.98B. The stock trades at 106.0× trailing earnings, 55.4× forward earnings and 1.3× sales. Over the trailing twelve months it earned $28.12M on revenue of $2.36B (a 1.2% profit margin) and burned $48.24M of free cash flow. Revenue grew 24.1% year over year.
As of its latest reported balance sheet, it holds $412.20M in cash and securities against $8.74B of debt, a net debt position of $8.33B.
Privia Health Group does not currently pay a dividend.
The share price is down 11.4% over the past year. At $22.62 (the Oct 15, 2026 close) it sits within its 52-week range of $18.91 to $28.82, below its 200-day moving average of $22.75.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $31.80, 40.6% above the Oct 15, 2026 close.
Frequently Asked Questions About Privia Health Group
What is the current stock price for PRVA?
As of the Oct 15, 2026 close, PRVA stock trades at $22.62. The 52-week range is $18.92–$28.82, with a day range of $21.89–$22.73.
What is the P/E ratio for PRVA?
As of the Oct 15, 2026 close, Privia Health Group's trailing twelve-month (TTM) P/E ratio is 106.0, meaning investors pay $106.0 for every $1 of annual earnings. The forward P/E is 55.4, reflecting analyst expectations for future earnings. Privia Health Group operates in the Healthcare sector.
Does PRVA pay dividends?
Privia Health Group does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRVA?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for PRVA is Buy. The average 12-month price target is $31.80, a 40.6% upside from the Oct 15, 2026 close of $22.62.
What is the market cap of PRVA?
As of the Oct 15, 2026 close, Privia Health Group's market capitalization is $2.98B, classifying it as a mid-cap company. Privia Health Group operates in the Healthcare sector within the Health Information Services industry.